Press release
Medication Adherence Market at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021
The global market for medication adherence reached $1.7 billion in 2016 and should reach nearly $4.0 billion by 2021 at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021.
Report Includes
16 additional tables and 24 additional tables
An overview of the global medication adherence market
Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021
Evaluations of clinical needs, competitive landscape, unmet needs, regulatory structure, and future outlook
An examination of the product types and the disease applications for medication adherence, along with chronic disorders
Evaluation of the market's dynamics, specifically growth drivers and restraints
Profiles of major players in the industry
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377245
Report Scope
Medication adherence include hardware-based systems (e.g., smart pill bottle, smart cap, automated pill dispenser, electronic trays, smart medical watches, smart medical alarms, wearable sensors, and other packaging systems) and software based internet applications (e.g., cloud-based databases, health programs, patient web portals, mobile medication management applications, etc.) to improve medication adherence associated with various chronic diseases. This report is an analytical business tool whose primary purpose is to provide a thorough evaluation of the global market for medication adherence. The format of this study includes the following:
Detailed description of medication adherence systems and technologies including software applications (apps).
Demographics and cost burden of targeted chronic diseases.
Market characterization, unmet need, market size, and segmentation.
Market drivers and restraints.
Detailed market projections through 2021.
Competition and market shares.
Key marketed and pipeline (R&D) products along with information about their regulatory status
Strategic landscape (Merger and acquisitions).
Regulatory structure.
Pricing and reimbursement.
Observations and conclusions on the future of medication adherence systems and technologies.
Profiles of market participants and associations.
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Target Diseases and Disorders
Cardiovascular Diseases (CVD)
Musculoskeletal Disorders
Gastrointestinal/Digestive Diseases
Common Gastrointestinal Diseases and Disorders
Angina Pectoris
Stroke
Hypertension
Epidemiology and Economic Burden
Mortality
Epidemiology and Economic Burden
Mortality
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/medication-adherence-systems-technologies-and-global-markets-report.html/toc
Inflammatory Bowel Disease (IBD)
Ulcer Disease
Esophagitis/Esophageal Diseases
Gastroesophageal Reflux Disease (GERD)
Obscure Gastrointestinal Bleeding
Celiac Disease
Breast Cancer
Colorectal Cancer
Small-bowel Tumors/Diseases
HIV/AIDS
Continue...
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on @ https://marketsizeinfo.blogspot.in/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Medication Adherence Market at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021 here
News-ID: 1567256 • Views: …
More Releases from Medication Adherence Market
Medication Adherence Market Report 2018 Companies included Koninklijke Philips N …
We have recently published this report and it is available for immediate purchase. For inquiry Email us on: jasonsmith@marketreportscompany.com *********
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides…
Global Medication Adherence Market is anticipated to witness a CAGR of 18.0% ove …
Albany, NY, 4th September : Recent research and the current scenario as well as future market potential of "Medication Adherence: Systems, Technologies and Global Markets" globally.
The global market for medication adherence reached $1.7 billion in 2016 and should reach nearly $4.0 billion by 2021 at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021.
Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377245
Report Includes
…
Global Medication Adherence Market 2021| Novartis, Pfizer, Roche, Sanofi, Merck …
Albany, NY, 27th July : Recent research and the current scenario as well as future market potential of "Medication Adherence: Systems, Technologies and Global Markets" globally.
The global market for medication adherence reached $1.7 billion in 2016 and should reach nearly $4.0 billion by 2021 at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021.
Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377245
Report Includes
…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
